Home/Filings/4/0001415889-25-019354
4//SEC Filing

Coll Crespo Blas 4

Accession 0001415889-25-019354

CIK 0001888886other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 5:15 PM ET

Size

13.0 KB

Accession

0001415889-25-019354

Insider Transaction Report

Form 4
Period: 2025-03-01
Coll Crespo Blas
Chief Medical Officer
Transactions
  • Award

    Ordinary Shares

    2025-07-01+7,992226,347 total
  • Award

    American Depositary Shares

    2025-05-21+4291,157 total
    Ordinary Shares (1,287 underlying)
  • Tax Payment

    Ordinary Shares

    2025-03-01$7.92/sh1,233$9,761218,355 total
  • Tax Payment

    Ordinary Shares

    2025-07-01$6.84/sh1,434$9,804224,913 total
Holdings
  • American Depositary Shares

    (indirect: By Spouse)
    Ordinary Shares (3,000 underlying)
    1,000
Footnotes (5)
  • [F1]The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
  • [F2]Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.
  • [F3]On March 15, 2024, the reporting person was granted performance-vesting restricted share units ("PSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer, which vest upon satisfaction of certain performance criteria. Certain of the performance criteria was determined to have been met effective July 1, 2025. The shares subject to the PSUs vest as follows: 50% of the shares vested on July 1, 2025 and the remainder will vest on January 1, 2027 subject to the reporting person's Continuous Service (as defined in the Structure Therapeutics Inc. 2023 Equity Incentive Plan) through such vesting date.
  • [F4]Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.
  • [F5]Voluntary reporting of the acquisition of 429 ADSs by the Reporting Person on May 21, 2025 pursuant to the Issuer's Employee Share Purchase Plan.

Issuer

Structure Therapeutics Inc.

CIK 0001888886

Entity typeother

Related Parties

1
  • filerCIK 0002037144

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:15 PM ET
Size
13.0 KB